REGN
赛诺菲和再生元制药公司称Dupixent获准在美国用于治疗大疱性类天疱疮。
时间:2025-06-20 13:03:39 市场: 美股 综合
Regeneron Pharmaceuticals Inc : Guggenheim Cuts Target Price to $950 From $1200
时间:2025-02-11 19:30:51 市场: 综合 美股
Bayer: Application Based on Positive Long-Term Results From Pulsar, Photon Trials Over Three Years
时间:2025-02-10 16:00:00 市场: 美股 综合
Bayer: Applies for Approval in the EU for 6-Month Treatment Interval With Eylea 8Mg
时间:2025-02-10 16:00:00 市场: 美股 综合
Eylea Hd® (Aflibercept) Injection 8 Mg Positive Phase 3 Results in Patients With Macular Edema Following Retinal Vein Occlusion Presented at Angiogenesis Meeting
时间:2025-02-09 06:40:18 市场: 美股
Regeneron Pharmaceuticals Inc - Announces Positive Three-Year Results for Eylea Hd in Wamd
时间:2025-02-09 04:56:25 市场: 美股 综合
Regeneron Pharmaceuticals Inc : TD Cowen Cuts Target Price to $970 From $1,030
时间:2025-02-05 14:16:35 市场: 美股 综合
Regeneron Pharmaceuticals Exec Says Eylea Net Sales Will Be Negatively Impacted in Q1 2025 as Increase in Inventory Is Absorbed - Conf Call
时间:2025-02-04 22:00:08 市场: 美股 综合
Regeneron Pharmaceuticals Shares up 2% Premarket After Q4 Profit Beat
时间:2025-02-04 19:38:24 市场: 美股 综合
Regeneron Pharmaceuticals Inc : TD Cowen Cuts Target Price to $1,030 From $1,230
时间:2025-01-29 20:36:30 市场: 美股 综合